ClinicalTrials.gg
CompletedNCT04648553Updated Nov 8, 2021

Task-Based Grounding Program

A Phase 1 interventional study of Task-Based Grounding and Connected Care (Enhanced Treatment as usual) in Aggressive, Defiant Disorder, Oppositional and Attention Deficit Hyperactivity Disorder, sponsored by Dartmouth-Hitchcock Medical Center. Completed at 1 site in United States. Open to participants aged 9 Years and older. Per ClinicalTrials.gov, last updated 2021-11-08.

Sponsored by Dartmouth-Hitchcock Medical Center · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
28
Allocation
Randomized
Ages
9 Years and older
Sex
All
01

Study summary

The purpose of this study is to improve the availability of brief interventions to help children with defiant, aggressive and disruptive behaviors by creating a brief scalable intervention for parents delivered via telehealth. As phase 1 study, we are conducting a 2-arm pilot feasibility RCT in order the intervention, measures, and procedures to be used in a larger efficacy trial. The first arm will include a 3-session behavioral therapy treatment we call Task-Based Grounding and the second arm will be an enhanced treatment as usual comparison group.

Read the detailed description

The investigators have developed a 3-session psychosocial intervention for parents of children between 9-14 with disruptive behaviors. The intervention uses telehealth visits along with written and online resources to teach them parent management skills. To evaluate the acceptability of this intervention and the feasibility of our methods, the investigators will recruit 20 parent-child dyads to participate in this study. This is a mixed methods pilot feasibility RCT design. The investigators designed this study to test the acceptability of the intervention to parents and test the feasibility of our recruitment, retention, measurement, and delivery mechanisms for both the experimental and comparison conditions. The investigators will use a block randomization method to separate parent-child dyads into either treatment or comparison groups. The treatment condition involves 3 telehealth visits and a set of parenting resources. The enhanced treatment as usual condition will involve contact with a "care navigator" that will assess behavior problems in the child and help the parents find an appropriate referral to care in their community. Both groups will be followed for 10 weeks, provide outcome data, and participate in semi-structured qualitative interviews to accept acceptability.

02

Conditions studied

  • Aggressive
  • Defiant Disorder, Oppositional
  • Attention Deficit Hyperactivity Disorder

Keywords

  • Oppositional Defiant Disorder
  • Behavioral Parent Training
03

In context

Aggression

248 studies on the registry are indexed under Aggression; 41 are open to participants now.

This study's enrollment of 28 is below the median of 80 across 221 interventional studies indexed under Aggression.

Browse Aggression studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 488 studies on the registry; 71 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Participating parent-child dyads must include a child between the ages of 9-14 years old and adult over the age of 18.
  • The child must have a Vanderbilt Oppositional Defiant Disorder score >3
  • The participating caregiver must be a legal guardian of participating child

Exclusion Criteria (child refers to the primary participant's child)

  • Child ever been hospitalized for a psychiatric problem
  • Child ever attempted suicide or stated that they had a plan to attempt suicide within the past year.
  • Child ever engaged in self-harm behaviors
  • Child has significant legal history such as adjudicated of a crime or been in diversion
  • Child has ever been diagnosed with: Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Intellectual Disability or Developmental Delay, Speech or Hearing Delay, Autism Spectrum Disorder, Schizophrenia or another psychotic disorder, A substance abuse disorder (or had serious concerns about substance use).
  • Parent can communicate in spoken English
  • Parent is under the age of 18.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Task-Based Grounding

    Participating parents will be provided with three 50-minute Task Based Grounding sessions using a standardized manual over 6 weeks.

    Behavioral: Task-Based Grounding

  • Sham comparator
    Connected Care (Enhanced treatment as usual)

    Participating parents will be provided with two sessions and one phone check-in call over 6 weeks. They will work with a "care navigator" to assess their child's needs, find them an appropriate referral for care, and help problem solve barriers to finding a therapist.

    Behavioral: Connected Care (Enhanced Treatment as usual)

Interventions

  • BehavioralTask-Based Grounding

    Three 50 minutes sessions with an interventionist that includes 6 non-punitive components of treatment common in Behavioral Parent Trainings: Education on behavior change, positive one-on-one time between parents and their children, differential attending to positive and negative behaviors, effective praise, giving effective instructions, and using a point and reward system to encourage prosocial behaviors. These components are distilled into 5 skill modules and paired with Task-Based Grounding, which involves a brief restriction of privileges and provides children with the opportunity to end the restriction by completing a prosocial task.

  • BehavioralConnected Care (Enhanced Treatment as usual)

    Two sessions with a facilitator. The facilitator does NOT provide any guidance to the parent on managing their child's behavior, but provides empathy and problem solving to help them find a resource that best fits their needs. It is particularly geared towards helping parents connect with Behavioral Parent Trainings to address the needs of children with oppositional, defiant, or aggressive behaviors.

06

What researchers measure

Primary outcomes

  1. Number of referred participants

    Feasibility of recruitment will be measured by number of participants referred

    Time frame: Through study completion, approximately 5 months.

  2. Number of participants who screen positive

    Feasibility of recruitment will be measured by number of participants who screen positive

    Time frame: Through study completion, approximately 5 months.

  3. Change from Baseline Session attendance at visit 3

    Feasibility of the participant retention in the program will be measured by session attendance by participants

    Time frame: Session attendance will be taken at Session 1 (week 0) and Session 3 (week 6)

  4. Number of participants enrolled

    Feasibility of recruitment will be measured by number of participants enrolled

    Time frame: Through study completion, approximately 5 months.

  5. Number of participants who complete all assessment measures

    Feasibility of assessment measures will be measured by number of participants who complete assessment measures

    Time frame: Through study completion, approximately 5 months.

  6. Fidelity of the training provided

    as measured by having a trained listener code and score fidelity using a checklist developed specifically for the content of each session. Audio recording of intervention sessions will be used. There are 35 items on the checklist, each worth 1pt. Score will be in terms of percentage, with a minimum score of 0 and a maximum score 100%.

    Time frame: Through study completion, approximately 5 months.

  7. Intervention acceptability as measured by the Treatment Evaluation Inventory Short Form

    as measured by Treatment Evaluation Inventory Short Form post intervention which measures intervention acceptance. The established cut off scores for determining if a treatment is acceptable is a score of 27. Min score possible is 0, max score possible is 32. Higher scores indicate greater acceptability.

    Time frame: Follow-up/post intervention (up to 10 weeks)

  8. Intervention Acceptability as measured by the Therapy Attitude Inventory

    as measured by the Therapy Attitude Inventory post intervention which measures acceptability of behavioral parent trainings. Min score of 1 is possible, max score of 50 is possible. Higher scores indicate greater acceptability.

    Time frame: Follow-up/post intervention (up to 10 weeks)

  9. Intervention Acceptability as measured by the Participant Experiences Questionnaire

    as measured by the Participant Experiences Questionnaire which measures acceptability of each skill module included in the program and is specific to program content. Min score of 0 possible, max score of 36 possible. Higher scores indicate greater acceptability.

    Time frame: Follow-up/post intervention (up to 10 weeks)

  10. Acceptability as measured by qualitative interview

    as measured by 30 minute semi-structured qualitative interview with participants conducted by a research assistant trained and supervised by the study PI

    Time frame: Follow-up/post intervention (up to 10 weeks)

Secondary outcomes

  1. Adherence to the intervention

    as measured by daily logs that track both children's aggressive and defiant behaviors and parenting behaviors. A count of each time a parent used a skill from the program will be used to estimate adherence and assess whether they matched the appropriate skills to the reported misbehaviors.

    Time frame: Available for completion every day for 10 weeks

07

Study locations

1 site
  • Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03756, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04648553
Responsible party
James T. Craig (Assistant Professor of Psychiatry, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Dec 1, 2020
Start date
Dec 3, 2020
Primary completion
Oct 1, 2021
Completion
Oct 1, 2021
Last update
Nov 8, 2021

Study contacts

James T Craig, Ph.D.
principal investigator · Dartmouth-Hitchcock Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion